Age ± stdev, y | 69.7 ± 6.6 |
Range | 55–82 |
PSA ± stdev, ng/mL | 9 ± 5.3 |
Range | 2.7–24.5 |
Gleason score 6 (%) | 25 |
Gleason score 7 (%) | 75 |
Primary GS 4 (%) | 47 |
Cores involved ± stdev (#) | 3.9 ± 2.4 |
Range | 1–9 |
Cores involved ± stdev (%) | 30 ± 19 |
Range | 10–75 |
Clinical stage: | |
 cT1c | 72 |
 cT2a | 17 |
 cT2b | 13 |
AUA score ± stdeva | 9 ± 7 |
Range | 0–20 |
SHIM score ± stdevb | 14 ± 8.7 |
Range | 0-26 |
Prostate volume ± stdev (cc) | 40.1 ± 22.5 |
Range | 13–108 |